Navigation Links
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
Date:1/8/2009

ty is a public health crisis, with more than 70 million Americans considered to be obese, according to the Centers for Disease Control. It is a chronic disease that is linked to serious medical conditions such as Type 2 diabetes, heart disease, blood pressure, stroke, depression and some forms of cancer. Obesity results from an energy imbalance associated with various environmental, behavioral and genetic factors making it a difficult and complicated condition to treat. However, there is a growing understanding of how the central nervous system regulates appetite and metabolism as well as the mechanisms that limit weight loss over time. This understanding is the basis of new strategies in drug development that we believe have the potential to change the way obesity is treated.

About Contrave

Contrave is an investigational oral weight loss medication with a unique mechanism of action that works at two levels within the central nervous system: one designed to control the balance of food intake and metabolism and another designed to control food preference, reward and cravings. We believe that Contrave may be the first treatment for obesity to target these reward centers in the central nervous system. Based on clinical trials completed to date, Contrave is believed to initiate and sustain significant weight loss over one year of treatment by reducing appetite, increasing metabolism and allowing the body to continue losing weight by offsetting its natural tendency to fight back and slow down the weight loss process.

About Orexigen(R) Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead combination product candidates targeted for obesity are Contrave, which is in Phase 3 clinical trials, and Empatic(TM), which is in the later stages of Phase 2 clinical development. Each product candidate is designed to act on
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
2. Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
3. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
4. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
5. Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences
6. Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008
7. OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
8. InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13
9. Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
10. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
11. Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , SHANGHAI, Nov. 30 /PRNewswire-...pharmaceutical, biotechnology, and medical-device ...operations in China and the United States,announc...ology Fast 50 China,2009 list for the fifth consec...wing companies in China,s technology, media, and t...
(Date:11/27/2009)..., , DURHAM, N.C., Nov. 27 /PRNewswire...k, will initiate water-soluble carbon nanotube-bas.... The water-soluble carbon nanotubes, which have f...ugation with cancer drugs, was developed in partne...he conjugated carbon nanotubes serves as a drug de...
(Date:11/25/2009)..., , BOSTON, Nov. 25 B... H1N1 virus, genomic data from the 1918 pandemic t...he current H1N1 pandemic, today issued its latest ...ows that the lethality of the H1N1 ("Swine Flu") v...uring the virus,s current outbreak in the spring o...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 ...arch report is available in its catalogue: ,, ... 2013 ,, http://www.reportlinker.com/p0165503...o-2013.html ,, Brazil Bioethanol Market Analys... report provides detailed analysis and forecasts o...
Breaking Biology Technology:WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
..., A Successful One , Ste...n of , Several Important Factor...termine if your gene of interest is , ... followed by gel , based staini... , PCR with SYBR Green I or T...
... The success of any RNA interference , ...livery of siRNA or siRNA , expr...ls. Many , researchers use cati... reagents to deliver these molecules into cul...oice of reagent and the conditions under which it ...
... , Ambion has developed a c..., of microRNAs (miRNAs). Recently, we introdu...rm (consisting of the mir Vana miRNA Labeling Kit...everal miRNA tools for interrogating , miRN...-miR miRNA Precursor , Molecules, Anti-miR ...
Other Biology Technology:Designing a Successful qRT-PCR Experiment 2Designing a Successful qRT-PCR Experiment 3Choose the Right Transfection Agent for Your RNAi Experiment 2Choose the Right Transfection Agent for Your RNAi Experiment 3Choose the Right Transfection Agent for Your RNAi Experiment 4Choose the Right Transfection Agent for Your RNAi Experiment 5Choose the Right Transfection Agent for Your RNAi Experiment 6Choose the Right Transfection Agent for Your RNAi Experiment 7Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 2Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 3Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 4Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 5Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 6Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 7Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 8
(Date:11/24/2009)... Rocket science is opening new doors to understan...ffect the hearing of a marine mammal or if they h...al sized X-ray scanners that NASA uses to detect f...ckets is now allowing scientists to peek inside th...etailed three-dimensional replicas of a whale,s he...
(Date:11/24/2009)... Springer and the American College of Medical Tox...rate on the publication of the Journal of Medical...MT, beginning in March 2010. It was previously pu..., The Journal of Medical Toxicology , an intern...vancing the science and practice of medical toxico...
(Date:11/24/2009)... Cambridge, Md. (November 24, 2009) New research...tic river ecosystems reveals predictable temporal ...se communities as markers for monitoring climate c...his week in the Proceedings of the National Acade...l communities in the six rivers shifted synchronou...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 1Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 2Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 3Cosmetic Use of Sculptra Now FDA Approved 54306 1Cosmetic Use of Sculptra Now FDA Approved 54306 2Cosmetic Use of Sculptra Now FDA Approved 54306 3Cosmetic Use of Sculptra Now FDA Approved 54306 4Seventh CyberKnife System in South Korea Purchased 13523 1Seventh CyberKnife System in South Korea Purchased 13523 2Seventh CyberKnife System in South Korea Purchased 13523 3
...iscovered a new gene that may put individuals at h..., The identification of the gene, called kalirin, ...ked to cardiovascular disease, according to the Du... this new clue could lead to novel ways to treat o... , "The ultimate goal is to determine who will ...
...they can safely drive while talking on their cell ... René Marois have found that when it comes to hand...sn,t that fast. , "Why is it that with our incre...llion neurons processing information at rates of u... a crippling inability to do two tasks at once?" M...
...f the Amazon, globalization is threatening the tim...eration to generation, with adverse effects on chi...ished online this week in the Proceedings of the N...at parents, and especially mothers, who know more ...hildren, independent of other factors such as educ...
Other Biology News:Tiny clue reveals new path toward heart disease 2Tiny clue reveals new path toward heart disease 3Neural bottleneck found that thwarts multi-tasking 2Neural bottleneck found that thwarts multi-tasking 3Mother knows best: Plant knowledge key to childhood health in remote Amazon 2
General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company
FlowJo from Tree Star Inc
...nome Sequencer 20 System revolutionizes DNA sequen...llel fashion. The Genome Sequencer 20 System incl...onsumables for library construction, amplification...d de novo assembly The instrument is the center...
...lytic degradation is critical to the maintenance o... proteins as important and diverse as those involv...esponse, antigen presentation, modulation of cell ...ulation, transcription, and signalling factors. Th...
Biology Products: